3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase EARLY_PHASE1
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Rectal Neoplasms
2
Ovarian Neoplasms
2
Fallopian Tube Neoplasms
2
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Resectable Pancreatic Carcinoma
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Glioma
1
Gastrointestinal Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Basal Cell
1
Interventions
Fluorodeoxyglucose F18
3
Oncolytic Virotherapy
2
Magnetic Resonance Spectroscopy
2
Cisplatin
2
weifuchun
1
sodium thiosulfate
1
s-formylglutathione hydrolase
1
lenvatinib
1
gallium 68 PSMA-11
1
X-Rays
1
Vitamins
1
Trastuzumab
1
Specimen Handling
1
Radiation
1
Platinum
1
Oxaliplatin
1
Nelfinavir
1
Hyperthermic Intraperitoneal Chemotherapy
1
Fluorouracil
1
FAPI-46
1
Esomeprazole
1
Epirubicin
1
Drug Therapy, Combination
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Carbohydrates
1
Amoxicillin
1
68Ga-DKFZ-PSMA-11
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Stomach Neoplasms
×
X-Rays
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled